Delivery Order SPE2DB20D9127-SPE2DB25FPRD9
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $16,483.21 to DMS Pharmaceutical Group Inc. for the supply of Cabometyx 40 mg tablets (30-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is scheduled for completion by August 20, 2025, and represents performance at the contractor's Park Ridge facility. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $16,434.34 to DMS Pharmaceutical Group Inc. for the supply of Cabometyx 60 mg tablets (30-count units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order represents a direct procurement with no set-aside designation. The award reflects performance under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $499.9 billion...
- The Defense Logistics Agency awarded a delivery order valued at $32,966.42 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cabometyx 40 mg tablets (30-count units). This firm fixed-price delivery order, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The...
- The Defense Logistics Agency awarded a delivery order valued at $16,483.21 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cabometyx 40 mg tablets (30-count units). This firm fixed-price delivery order, issued on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a typical transactional procurement under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,483.21 by the Defense Logistics Agency on September 3, 2025, for the supply of Cabometyx 40 mg tablets (30-count units). This firm fixed-price delivery order, with an ultimate completion date of September 4, 2025, was issued without a set-aside designation. The award is issued under DMS Pharmaceutical Group's existing single-award...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,966.42 to DMS Pharmaceutical Group Inc. for the supply of Cabometyx 40 mg tablets (30-count units) on September 17, 2025, with completion targeted for September 18, 2025. This firm fixed-price delivery order, issued without a set-aside designation, leverages DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price delivery order valued at $16,483.21 for Cabometyx 40 mg tablets (30-count units). The contract, awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency for the supply of Cabometyx 40 mg tablets (30-count units). This firm fixed-price delivery order, valued at $16,483.21, was issued on September 5, 2025, with an ultimate completion date of September 8, 2025. The award carries no set-aside designation, allowing the company to compete on an open basis despite its...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $33,265.08 for the supply of Cabometyx 20 mg tablets (30-count units) on September 2, 2025. This award, with an ultimate completion date of September 3, 2025, carries no set-aside designation and will be performed at the contractor's Park Ridge facility. The delivery order is funded by the Defense Logistics Agency's Medical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,434.34 by the Defense Logistics Agency on July 30, 2025, for the supply of Cabometyx 60 mg tablets (30-count units). The delivery order is issued without a set-aside designation and is scheduled for completion by July 31, 2025. This award falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery...
- SPE2DB20D9127Indefinite Delivery Contract
- SPE2DB20D9127-SPE2DB25FPRD9Delivery Order
The U.S. Defense Logistics Agency awarded a delivery order valued at $16,483.21 to DMS Pharmaceutical Group Inc. for the supply of Cabometyx 40 mg tablets (30-count units). This award, issued on August 19, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, and will be performed at the contractor's facility in Park Ridge, Illinois. The contract utilizes no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, holds a significant position within the Defense Logistics Agency's pharmaceutical supply chain through its $499,999,999 Indefinite Delivery Contract under the SPE2DB program, valid through November 2026. This delivery order for Cabometyx—a prescription medication used in oncology treatment—exemplifies the company's core business of distributing branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare facilities nationwide. The award reflects DMS Pharmaceutical Group's established capability and performance as a critical supplier of pharmaceutical products supporting Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.5k | 8/19/25 |